Targeting the procarcinogenic products of inflammation like free radicals, arachidonic acid metabolites, NFκB transcription factor, TNF-alpha (TNF-α), CXC chemokines and AKT can be an important approach to halt cancer development and progression. This evidence concerns the gene TNF and cancer.